Focus: Oruka Therapeutics is a clinical-stage biotech focused on biologic therapies for dermatological diseases, headquartered in Waltham, MA. The company is advancing a pipeline centered on plaque psoriasis and related skin indications.
Profile data last refreshed 20h ago · AI intelligence enriched 3w ago
Cooling — net -6 jobs in 30d
5 added, 11 removed. Slower than typical.
Oruka is a solid mid-stage biotech bet for professionals seeking exposure to dermatology biologics and upside equity participation, but requires tolerance for clinical-stage risk and a 3–5 year horizon before potential commercialization.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Oruka Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Oruka Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
ORKA Stock Climbs As Traders Track Tight Range - StocksToTrade
ORKA Stock Climbs As Traders Track Tight Range StocksToTrade
ORKA Stock Grinds Higher As Traders Track Tight Range - timothysykes.com
ORKA Stock Grinds Higher As Traders Track Tight Range timothysykes.com
ORKA Stock Climbs As Traders Track Strong Cash Runway - StocksToTrade
ORKA Stock Climbs As Traders Track Strong Cash Runway StocksToTrade
Form 144 ORUKA THERAPEUTICS INC For: 15 July By Investing.com - Investing.com Australia
Form 144 ORUKA THERAPEUTICS INC For: 15 July By Investing.com Investing.com Australia
Form 4 Oruka Therapeutics Inc For: 15 July By Investing.com - Investing.com Nigeria
Form 4 Oruka Therapeutics Inc For: 15 July By Investing.com Investing.com Nigeria
Form 4 Oruka Therapeutics Inc For: 15 July By Investing.com - Investing.com South Africa
Form 4 Oruka Therapeutics Inc For: 15 July By Investing.com Investing.com South Africa
Showing 6 of 10 news items
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles